ADVERTISEMENT

Bharat Biotech

G20 delegates visit Bharat Biotech's Genome Valley unit

One of the key features of the Genome Valley is the presence of several research and innovation institutions

07 June 2023, 07:19 IST

G20 delegates visit Bharat Biotech's Genome Valley plant, term it shining star

G20 delegates visit Bharat Biotech's Genome Valley plant, term it shining star

G20 delegates visit Bharat Biotech's Genome Valley unit

07 June 2023, 07:19 IST

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

'iNCOVACC' is priced at Rs 800 for private markets and at Rs 325 for supplies to the government of India and state governments

26 January 2023, 10:48 IST

Union Minister Mansukh Mandaviya launches Bharat Biotech's nasal Covid vaccine iNCOVACC

Union Minister Mansukh Mandaviya launches Bharat Biotech's nasal Covid vaccine iNCOVACC

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

26 January 2023, 10:48 IST

First Indian intranasal Covid vax to be out on Jan 26

In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government

21 January 2023, 14:37 IST

First Indian intranasal Covid vaccine to be launched on January 26

First Indian intranasal Covid vaccine to be launched on January 26

First Indian intranasal Covid vax to be out on Jan 26

21 January 2023, 14:37 IST

NTAGI chief says can't take nasal vaccine after booster

The NTAGI chief has been involved with the vaccine process from its inception to the rollout of the doses, to booster shots up until now

28 December 2022, 09:51 IST

NTAGI chief says nasal vaccine not for those who already got booster dose

NTAGI chief says nasal vaccine not for those who already got booster dose

NTAGI chief says can't take nasal vaccine after booster

28 December 2022, 09:51 IST

Bharat Biotech nasal vax to cost ₹800 at pvt hospitals

The intranasal vaccine is the first to get approval for the primary 2-dose schedule and as a heterologous booster dose

27 December 2022, 16:26 IST

Bharat Biotech's nasal vaccine iNCOVACC priced at Rs 800 for pvt hospitals, Rs 325 for government

Bharat Biotech's nasal vaccine iNCOVACC priced at Rs 800 for pvt hospitals, Rs 325 for government

Bharat Biotech nasal vax to cost ₹800 at pvt hospitals

27 December 2022, 16:26 IST

Bharat Biotech demands intranasal Covid vax on Co-WIN

Bharat Biotech’s Covaxin, Serum Institute’s Covishield and Covovax, Russian Sputink V and Biological E Ltd’s Corbevax are listed in the Co-Win portal

11 December 2022, 09:14 IST

Bharat Biotech urges Centre to include its intranasal Covid vaccine in Co-WIN portal

Bharat Biotech urges Centre to include its intranasal Covid vaccine in Co-WIN portal

Bharat Biotech demands intranasal Covid vax on Co-WIN

11 December 2022, 09:14 IST

iNCOVACC Covid nasal vaccine gets CDSCO nod for booster

The vaccine candidate was evaluated in Phases I, II and III clinical trials with successful results

28 November 2022, 14:25 IST

Bharat Biotech's iNCOVACC Covid intranasal vaccine gets CDSCO nod for booster doses

Bharat Biotech's iNCOVACC Covid intranasal vaccine gets CDSCO nod for booster doses

iNCOVACC Covid nasal vaccine gets CDSCO nod for booster

28 November 2022, 14:25 IST

Covaxin approval not due to political pressure: Govt

The ministry said CDSCO followed a scientific approach and prescribed norms in approving Covid vaccines for emergency use authorisation

17 November 2022, 15:17 IST

Government junks claims of Covaxin approval due to political pressure

Government junks claims of Covaxin approval due to political pressure

Covaxin approval not due to political pressure: Govt

17 November 2022, 15:17 IST

Nasal Covid jab: BB seeks nod for trials for 5-18 yrs

Now the Hyderabad based firm has submitted an application seeking permission to conduct phase-3, multicenter study to evaluate the safety, an official told

11 September 2022, 08:35 IST

Bharat Biotech seeks regulator nod for phase-3 study of intranasal Covid vaccine in 5-18 age group

Bharat Biotech seeks regulator nod for phase-3 study of intranasal Covid vaccine in 5-18 age group

Nasal Covid jab: BB seeks nod for trials for 5-18 yrs

11 September 2022, 08:35 IST

Bharat Biotech's nasal Covid vaccine gets DCGI approval

More than 86 crore Indians have received two doses of the Covid-19 vaccines so far, but the uptake of the precautionary third shot remains low

06 September 2022, 16:16 IST

Bharat Biotech's nasal Covid-19 vaccine gets DCGI approval

Bharat Biotech's nasal Covid-19 vaccine gets DCGI approval

Bharat Biotech's nasal Covid vaccine gets DCGI approval

06 September 2022, 16:16 IST